“These 3 Penny Stocks Have Massive Upside Potential, Says Cowen”
October 20, 2020
“Neos Therapeutics (NEOS)…
Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target is even more aggressive than Cacciatore’s and implies 1674% upside potential…
Dynavax Technologies (DVAX)…
Other analysts echo Nadeau’s sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $16, the upside potential comes in at 276%…
La Jolla Pharmaceutical (LJPC)…
What does the rest of the Street have to say? When it comes to other analyst activity, it has been relatively quiet. 2 Buys and no Holds or Sells have been issued in the last three months. Therefore, LJPC gets a Moderate Buy consensus rating. Based on the $14 average price target, shares could skyrocket 251% in the next year…”
https://finance.yahoo.com/news/3-penny-stocks-massive-upside-193058024.html